This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Shyra Gardai, Ph.D.
Chief Scientific Officer at EpiBiologics
Speaker

Profile

Shyra Gardai is the Chief Scientific Officer at EpiBiologics. Shyra brings over 20 years of experience as an executive manager leading innovative discovery research groups focused on turning novel ideas into clinical stage therapies to battle cancer, autoimmune, and neurodegenerative diseases. During her time at Elan Pharmaceuticals and Seagen, Shyra headed the discovery and delivery of over 6 phase 1 clinical candidates that integrated novel antibody, chemistry, and protein engineering technologies. Most recently Shyra was the Vice President of Therapeutic Discovery Research at Seagen where she led a 60+ member team comprised of chemists, protein engineers, immunologist and cancer biologist focused on discovering new treatments for cancer patients. Shyra trained as an Immunologist at the University of Colorado and went on to complete a postdoctoral research fellowship in the Department of Immunology at National Jewish Health.

Agenda Sessions

  • EpiTACs Are a Novel Bispecific Antibody Platform that Drive the Degradation of Disease-Driving Targets

    4:45pm